Therapeutic efficacy of intra-arterial administration of induced pluripotent stem cells-derived neural progenitor cells in acute experimental ischemic stroke in rats

Aim. Neural progenitor cells (NPC) are used for the development of cell therapies of neurological diseases. Their stereotaxic transplantation in the middle cerebral artery occlusion (MCAO) model imitating ischemic stroke results in symptom aleviation. However, exploration of less invasive transplantation options is essential, because stereotaxic transplantation is a complex procedure and can be applied to humans only by vital indications in a specialized neurological ward. The aim of the present study was to evaluate the efficacy of cell therapy of the experimental ischemic stroke by the intra-arterial transplantation of NPC.

Materials and methods. NPC for transplantation (IPSC-NPC) were derived by two-stage differentiation of cells of a stable line of human induced pluripotent stem cells. Stroke modeling in rats was carried out by transitory 90 min endovascular MCAO by a silicon-tipped filament. NPC were transplanted 24 hours after MCAO. Repetitive magnetic resonance tomography of experimental animals was made with the Bruker BioSpin ClinScan tomograph with 7 Tl magnetic field induction. Animal survival rate and neurological deficit (using mNSS standard stroke severity scale) were evaluated at the 1st (before IPSC-NPC transplantation), 7th and 14th day after transplantation. Histological studies were carried out following standard protocols.

Results. Intra-arterial transplantation of 7 × 10⁵ IPSC-NPC in 1 ml at a constant 100 l/min rate in case of secured blood flow through the internal carotid artery did not cause brain capillary embolism, additional cytotoxic brain tissue edemas or other complications, while inducing increase of animal survival rate and enhanced revert of the neurological deficit. IPSC-NPC accumulation in brain after intra-arterial infusion was demonstrated. Some cells interacted with the capillary endothelium and probably penetrated through the blood-brain barrier.

Conclusion. Therapeutic efficacy of the systemic, intra-arterial administration of NPC in ischemic stroke has been experimentally proven. A method of secure intra-arterial infusion of cell material into the internal carotid artery middle in rats has been developed and tested.

1. Sinden JD, Hicks C, Stroemer P, Vishnubhatla I, Corteling R. Human Neural Stem Cell Therapy for Chronic Ischemic Stroke: Charting Progress from Laboratory to Patients. Stem Cells Dev. 2017; 26 (13): 933–947. doi: 10.1089/scd.2017.0009.

2. Oki K, Tatarishvili J, Wood J, Koch P, Wattananit S, Mine Y et al. Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain. Stem Cells. 2012; 30 (6): 1120–1133. doi: 10.1002/stem.1104.

3. Polentes J, Jendelova P, Cailleret M, Braun H, Romanyuk N, Tropel P et al. Human induced pluripotent stem cells improve stroke outcome and reduce secondary degeneration in the recipient brain. Cell Transplant. 2012; 21 (12): 2587–2602. doi: 10.3727/096368912X653228.

4. Nekrasov ED, Vigont VA, Klyushnikov SA, Lebedeva OS, Vassina EM, Bogomazova AN et al. Manifestation of Huntington’s disease pathology in human induced pluripotent stem cell-derived neurons. Mol Neurodegener. 2016; 11: 27. doi: 10.1186/s13024-016-0092-5.

5. Koizumi J-i, Yoshida Y, Nakazawa T, Ooneda G. Experimental studies of ischemic brain edema 1. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Nosotchu. 1986; 8 (1): 1–8. doi: 10.3995/jstroke.8.1.

6. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989; 20 (1): 84–91.

7. Gubskiy IL, Namestnikova DD, Cherkashova EA, Chekhonin VP, Baklaushev VP, Gubsky LV et al. MRI Guiding of the Middle Cerebral Artery Occlusion in Rats Aimed to Improve Stroke Modeling. Transl Stroke Res. 2018; 9 (4): 417–425. doi: 10.1007/s12975-017-0590-y.

8. Namestnikova D, Gubskiy I, Gabashvili A, Sukhinich K, Melnikov P, Vishnevskiy D et al. MRI evaluation of frequent complications after intra-arterial transplantation of mesenchymal stem cells in rats. Journal of Physics: Conference Series. 2017; 886 (1): 012012.

9. Boltze J, Kowalski I, Geiger K, Reich D, Gunther A, Buhrle C et al. Experimental treatment of stroke in spontaneously hypertensive rats by CD34+ and CD34– cord blood cells. Ger Med Sci. 2005; 3: Doc09.

10. Seltmann S, Lekschas F, Muller R, Stachelscheid H, Bittner MS, Zhang W et al. hPSCreg – the human pluripotent stem cell registry. Nucleic Acids Res. 2016; 44 (D1): D757–63. doi: 10.1093/nar/gkv963.

11. Liu J. Induced pluripotent stem cell-derived neural stem cells: new hope for stroke? Stem Cell Res Ther. 2013; 4 (5): 115. doi: 10.1186/scrt326.

12. von Kummer R, Broderick JP, Campbell BC, Demchuk A, Goyal M, Hill MD et al. The Heidelberg Bleeding Classification: Classification of Bleeding Events After Ischemic Stroke and Reperfusion Therapy. Stroke. 2015; 46 (10): 2981–2986. doi: 10.1161/STROKEAHA.115.010049.